RGC
Roberts, Glore & Co’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,223
| Closed | -$964K | – | 203 |
|
|
2024
Q4 | $964K | Sell |
5,223
-63
| -1% | -$11.6K | 0.29% | 81 |
|
|
2024
Q3 | $1.04M | Sell |
5,286
-115
| -2% | -$22.7K | 0.3% | 82 |
|
|
2024
Q2 | $1.12M | Sell |
5,401
-5
| -0.1% | -$1.03K | 0.34% | 75 |
|
|
2024
Q1 | $1.46M | Sell |
5,406
-75
| -1% | -$20.3K | 0.44% | 63 |
|
|
2023
Q4 | $1.3M | Buy |
5,481
+578
| +12% | +$137K | 0.4% | 67 |
|
|
2023
Q3 | $961K | Sell |
4,903
-15
| -0.3% | -$2.94K | 0.32% | 79 |
|
|
2023
Q2 | $1.03M | Buy |
4,918
+1,198
| +32% | +$252K | 0.33% | 73 |
|
|
2023
Q1 | $751K | Buy |
3,720
+2,580
| +226% | +$521K | 0.25% | 86 |
|
|
2022
Q4 | $248K | Buy |
+1,140
| New | +$248K | 0.09% | 162 |
|